secwatch.observer — SEC 8-K summary
======================================

Issuer:     Innovation1 Biotech Inc. (—)
CIK:        0001629205
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0001477932-22-008514
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Innovation1 Biotech sells Mioxal® assets to Ingenius Biotech for stock and royalties
--------------------------------------------------------------------------------

- Company transferred all Mioxal-related assets including IP to Ingenius Biotech S.L.
- Consideration includes 350,000 shares of Innovation1 common stock to Ingenius.
- Ingenius to pay $100,000 upon first sale/commercialization and a 5% royalty on net sales.
- Ingenius releases Innovation1 from all Mioxal liabilities and provides indemnification.
- Transaction completed on November 7, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1629205/000147793222008514/0001477932-22-008514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1629205/000147793222008514/ivbt_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-22-008514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer